S. Liew (Kuala Lumpur, Malaysia), T. Maricoto (Aveiro, Portugal)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Recognising the long-term burden of short course oral corticosteroids
L. Heaney (Belfast (Belfast), United Kingdom), F. Schleich (Liege, Belgium), S. Korn (Mainz, Germany), P. Howarth (London, United Kingdom), Z. Antoun (London, United Kingdom), A. Bourdin (Montpellier, France), G. Canonica (Milan, Italy)
|   |
Short-acting ß2-agonists and greenhouse gas emissions in Europe and Canada
C. Janson (Uppsala, Sweden), E. Maslova (Cambridge, United Kingdom), A. Wilkinson (Stevenage, United Kingdom), E. Penz (Saskatoon, Saskatchewan, Canada), A. Papi (Ferrara, Italy), N. Budgen (Macclesfield, United Kingdom), C. Vogelmeier (Marburg, Germany), M. Kupczyk (Lodz, Poland), J. Bell (Cambridge, United Kingdom), A. Menzies-Gow (London, United Kingdom)
| |
Greenhouse gas emissions associated with COPD care in the UK: Results from SHERLOCK CARBON
J. Bell (Cambridge, United Kingdom), B. Ding (Gothenburg, Sweden), E. De Nigris (Cambridge, United Kingdom), J. Haughney (Glasgow, United Kingdom)
| |
Exploring the provision of supportive care for people with severe, potentially life limiting chronic obstructive pulmonary disease in Malaysia: a qualitative study
S. Liew (Kuala Lumpur, Malaysia), E. Khoo (Kuala Lumpur, Malaysia), H. Pinnock (Edinburgh, United Kingdom), S. Mccarthy (Kuala Lumpur, Malaysia), Z. Lim (Kuala Lumpur, Malaysia), Y. Pang (Kuala Lumpur, Malaysia), N. Hanafi (Kuala Lumpur, Malaysia), N. Hussein (Kuala Lumpur, Malaysia), A. Abu Bakar (Kuala Lumpur, Malaysia), Y. Chan (Kuala Lumpur, Malaysia), A. Sheikh (Edinburgh, United Kingdom)
| |
Adherence to medication advice through a remote electronic asthma and COPD service
N. Schipper (Groningen, Netherlands), A. Baron (Groningen, Netherlands), B. Flokstra-De Blok (Groningen, Netherlands), H. Wouters (Groningen, Netherlands), E. Metting (Groningen, Netherlands), E. Van Heijst (Groningen, Netherlands), R. Riemersma (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), J. Kocks (Groningen, Netherlands)
| |
Association between patient-reported outcomes and functional test outcomes in patients with COPD before undergoing home-based pulmonary rehabilitation.
R. Vilarinho (Lisbon, Portugal), C. Esteves (Lisbon, Portugal), C. Caneiras (Lisbon, Portugal)
| |
Patient perspectives on systemic corticosteroids in asthma
M. Fletcher (Edinburgh, United Kingdom), T. Winders (Vienna, United States of America), J. Oppenheimer (Cedar Knolls, NJ, , United States of America), P. Howarth (London, United Kingdom), Z. Antoun (London, United Kingdom), T. Van Der Molen (Groningen, Netherlands), M. Thomas (Southampton , United Kingdom)
| |
Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
J. Suggett (London (ON), Canada), M. Nagel (London (ON), Canada), C. Doyle (London (ON), Canada), R. Ali (London (ON), Canada)
| |
Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
C. Pinto (Salvador (BA), Brazil), A. Vale (Salvador (BA), Brazil), P. Lauton (Salvador (BA), Brazil), L. Costa (Salvador (BA), Brazil), A. Lemos (Salvador (BA), Brazil)
| |
Characteristics of COPD patients prescribed ICS managed in general practice vs. secondary care
O. Savran (Hvidovre, Denmark), N. Godtfredsen (Hvidovre, Denmark), T. Sørensen (Værløse, Denmark), C. Jensen (Præstø, Denmark), C. Suppli Ulrik (Hvidovre, Denmark)
| |
An electronic patient decision aid comparing as-needed budesonide-formoterol combination to regular use of inhaled corticosteroid (ICS) in mild asthma: a rapid-cycle design study
M. Gagne (Toronto, Canada), J. Lam Shin Cheung (Toronto, Canada), A. Kouri (Toronto, Canada), L. Boulet (Québec, Canada), J. Fitzgerald (Vancouver, Canada), A. Grill (Toronto, Canada), P. O'Byrne (Hamilton, Canada), S. Gupta (Toronto, Canada)
| |
How to improve patient adherence to spacers: Results from a patient survey following introduction of a new spacer designed to help use ‘On the Go’
J. Suggett (London (ON), Canada), A. Ellery (London (ON), Canada)
| |
Acceptability of healthcare professionals to get vaccinated against COVID-19 two weeks before initiation of national vaccination in Greece
A. Pataka (Thessaloniki, Greece), S. Kotoulas (Thessaloniki, Greece), E. Stefanidou (Thessaloniki, Greece), I. Grigoriou (Thessaloniki, Greece), . Tsiouprou (Thessaloniki, Greece), P. Argyropoulou (Thessaloniki, Greece)
| |
Exploring the psychological impact of the COVID-19 pandemic on adults with asthma: A quantitative study
K. McClatchey (Edinburgh, United Kingdom), T. Jackson (Edinburgh, United Kingdom), E. Kinley (Edinburgh, United Kingdom), A. Chan (Auckland, New Zealand), N. Morgan (Edinburgh, United Kingdom), J. Rees (Edinburgh, United Kingdom), H. Pinnock (Edinburgh, United Kingdom)
| |
Exploring the psychological impact of the COVID-19 pandemic on adults with asthma: a qualitative study
T. Jackson (Edinburgh, United Kingdom), K. Mcclatchey (Edinburgh, United Kingdom), A. Chan (Auckland, New Zealand), N. Morgan (Edinburgh, United Kingdom), H. Pinnock (Edinburgh, United Kingdom)
| |
Daily spirometry in Covid-19 positive patients
M. Bhakare (Pune, Maharashtra, India), R. Nikalje (Pune, Maharashtra, India), R. Patil (Pune, Maharashtra, India), U. Shukla (Pune, Maharashtra, India), R. Bokade (Pune, Maharashtra, India), G. Sakhare (Pune, Maharashtra, India), S. Joshi (Pune, Maharashtra, India), A. Pais (Pune, Maharashtra, India)
| |
Anxiety and Depression Levels of Healthcare Workers During COVID-19 Pandemic
M. Turan (Izmir, Turkey), N. Yilmaz Demirci (Ankara, Turkey), G. Ak (Eskisehir, Turkey), S. Akçay (Ankara, Turkey), U. Aka Akturk (Istanbul, Turkey), S. Bilaçeroglu (Izmir, Turkey), F. Coskun (Bursa, Turkey), O. Köktürk (Ankara, Turkey), A. Mirici (Çanakkale, Turkey), C. Özdemi?r (Istanbul, Turkey), N. Sen (Adana, Turkey), Ü. Yilmaz (Ankara, Turkey)
| |
Hyperventilation as a possible explanation for exercise intolerance in young athletes after mild COVID-19
O. Fesenko (Moscow, Russian Federation)
| |